CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $530.48 | $127K | 333,703 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,024 | $531.54 | $544K | 332,679 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,378 | $532.46 | $1.3M | 330,301 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,818 | $533.32 | $970K | 328,483 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $534.41 | $342K | 327,843 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −535 | $535.67 | $287K | 327,308 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −865 | $536.66 | $464K | 326,443 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −760 | $537.74 | $409K | 325,683 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −401 | $538.55 | $216K | 325,282 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −239 | $539.60 | $129K | 325,043 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −169 | $541.62 | $92K | 324,874 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −391 | $542.67 | $212K | 324,483 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $543.85 | $22K | 324,443 |
| 2026-10-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 214,410 | ||
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −268 | $541.64 | $145K | 53,204 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,924 | $542.49 | $1.0M | 51,280 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,983 | $543.56 | $1.1M | 49,297 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −791 | $544.85 | $431K | 48,506 |
| 2026-10-15 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,615 | $545.69 | $1.4M | 45,891 |
Page 17 of 120 · 2,391 trades